Speaker illustration

Doctor Daniel Lavall

University Hospital Leipzig, Leipzig (Germany)

Member of:

European Society of Cardiology

Left ventricular fibrosis influences the time to recovery in patients with arrhythmia-induced cardiomyopathy

Event: ESC Congress 2023

Topic: Late Gadolinium Enhancement

Session: CMR tissue characterisation: why it matters


Ventricular-arterial coupling and sacubitril/valsartan treatment in patients with heart failure and reduced ejection fraction

Event: Heart Failure 2023

Topic: Haemodynamics of Heart Failure

Session: Chronic heart failure - pathophysiology and mechanisms 3


Effects of Sacubitril/Valsartan on left ventricular pressure-volume relationship in heart failure

Event: ESC Congress 2022

Topic: Myocardial Disease

Session: Acute and chronic heart failure: echocardiographic characterisation


Cardiac magnetic resonance T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy

Event: Heart Failure 2022

Topic: Imaging

Session: Imaging in chronic heart failure


Native T1 mapping for differential diagnosis of left ventricular hypertrophy

Event: EuroCMR 2021

Topic: Myocardial Disease

Session: ePoster session


Left ventricular mechanical dispersion in flow-gradient patterns of severe aortic stenosis

Event: ESC Congress 2020

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Echocardiography ePosters


The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling

Event: ESC Congress 2019

Topic: Ventricular Remodelling

Session: Basic science heart failure


Long-term hemodynamic improvement after transcatheter repair of secondary mitral regurgitation

Event: EuroEcho-Imaging 2018

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease


Predictors for clinical improvement after transcatheter mitral valve repair

Event: ESC Congress 2018

Topic: Intervention

Session: Best Posters in mitral regurgitation


Rac1 GTPase regulates 11beta Hydroxysteroid Dehydrogenase Type 2, which is associated with structural cardiac remodeling

Event: ESC Congress 2017

Topic: Growth factors, neurohormones and signal transduction-cardiac

Session: Lipids, cardiac pathology


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb